Recurrent atypical hemolytic uremic syndrome, manifested in severe pancreas lesion
Abstract
About the Authors
A. M. KuchievaRussian Federation
N. L. Kozlovskaya
Russian Federation
K. A. Demyanova
Russian Federation
I. A. Dobrosmyslov
Russian Federation
References
1. Afshar-Kharghan V. Unleashed platelets in aHUS // Blood. 2008. Vol. 111. P. 5266.
2. Amara U., Flierl M.A., Rittirsch D. et al. Molecular intercommunication between the Complement and Coagulation systems // The J. of Immunology. 2010. Vol. 185. P. 5628–5636.
3. Besbas N., Karpman D., Landau D. et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, and related disorders // Kidney Int. 2006. Vol. 70. P. 423–431.
4. Caprioli J., Noris M., Brioschi S. et al. Genetics of HUS: the impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome // Blood. 2006. Vol. 108. P. 1267–1279.
5. Chandler W.L., Jelacic S., Boster D.R. et al. Prothrombotic coagulation abnormalities preceeding the hemolytic-uremic syndrome // N. Engl. J. Med. 2002. Vol. 346. P. 23–32.
6. Fakhouri F., Fremeaux-Bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? // Nat. Clin. Pract. Nephrol. 2007. Vol. 3. P. 679–687.
7. Grabowski E.F. The hemolytic-uremic syndrome – toxin, thrombin and thrombosis // N. Engl. J. Med. 2002. Vol. 346. P. 58–61.
8. Hosler G.A., Cusumano A.M., Hutchins G.M. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases // Arch. Pathol. Lab. Med. 2003. Vol. 127. P. 834–839.
9. Huber-Lang M., Sarma F.S., Zetoune D. et al. Generation of C5a in the absence of C3: a new complement activation pathway // Nat. Med. 2006. Vol. 12. P. 682–687.
10. Kitchens C.S., Erkan D., Branda~o L.R. et al. Thrombotic storm revisited: preliminary diagnostic criteria suggested by the Thrombotic storm study group // Am. J. Med. 2011. Vol. 12. P. 290–296.
11. Kitchens C.S. Thrombotic storm: when thrombosis begets thrombosis // Am. J. Med. 1998. Vol. 104. P. 381–385.
12. Licht C., Pluthero F.G., Li L. et al. Platelet-associated complement factor H in healthy persons and patients with atypical HUS // Blood. 2009. Vol. 114. P. 4538–4545.
13. Loirat C., Noris M., Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children // Pediatr. Nephrol. 2008. Vol. 23. P. 1957–1972.
14. Mutch N.R., Robbie L.A., Booth N.A. Human thrombi contain an abundance of active thrombin // Thromb. Haemost. 2001. Vol. 86. P. 1028–1034.
15. Noris M., Caprioli J., Bresin E. et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype // Clin. J. Am. Soc. Nephrol. 2010. Vol. 5. P. 1844–1859.
16. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome // N. Engl. J. Med. 2009. Vol. 361. P. 1676–1687.
17. Stahl A.L., Vaziri-Sani F., Heinen S. et al. Factor H dysfunction in patients with hemolytic uremic syndrome contributes to complement deposition on platelets and their activation // Blood. 2008. Vol. 111. P. 5307–5315.
18. Swisher K.K., Doan J.T., Vesely S.K. et al. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports // Haematologica. 2007. Vol. 92. P. 936–943.
19. Van Geet C., Proesmans W., Arnout J. et al. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome // Kidney. Int. 1998. Vol. 54. P. 1324–1330.
Review
For citations:
Kuchieva A.M., Kozlovskaya N.L., Demyanova K.A., Dobrosmyslov I.A. Recurrent atypical hemolytic uremic syndrome, manifested in severe pancreas lesion. Nephrology and Dialysis. 2013;15(3):236-239. (In Russ.)